enterpris softwar softwar servic
great busi wait buy stock
veeva analyst day reinforc mani posit attribut underpin favor
view firm fundament opportun ahead core life scienc still
quit larg firm reput buyer combin steadi stream
innov creat moat result stand sever
year subscript growth best-in-class margin updat
presum come littl surpris bullish investor push stock
ev/fcf estim certain extent think theyr right crowd
perceiv safe-haven support real cash gener good strategi
uncertain tape acknowledg continu keep valuation-bas hold
stock hard advoc increment buy level
right question step buy stock ideal world wed
like trade around notion trade rang forward akin
name like trade normal would mean step somewher
middl weve miss mani bottom wait perfect
entri point fan favorit like rare get cheap valuat sensit
buyer would like weve said past report use market pullback upgrad
qualiti portfolio gener good strategi shop
list say right price step mean stock closer high
valuat name space correct news week suggest
readi get chanc well continu wait
takeaway analyst day
new goal veeva firm outlin new target aim take
busi run-rat today revenu next year
impli revenu compound-annual-growth-rate assum veeva reach
goal earli firm hit six quarter ahead target like see anoth
half-decad growth top veeva commit oper
margin tell us invest could step bit year ahead
note manag qualifi target mostli organ mostli life scienc
addit color crossix announc thursday last week plu
earnout addit bring data scienc capabl help life scienc brand
better optim market campaign inclus patient data analyt
capabl add anoth veeva bottom-up take north
roughli run-rat revenu crossix expect gener
revenu approxim growth firm expect gener
stand-alone oper margin
three key area innov order import view that
opportun clinic data manag cdm develop industri first
clinic network addit traction ai stand-alone app embed
technolog particular note cdm front manag detail progress
develop clinic databas clinic queri languag cql essenti
new piec special system softwar make clinic data easili
searchabl critic compon faster develop better patient outcom
price close busi octob
content manag master data softwar
solut life scienc industri
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
still earli day think back number call field
narrow time shortli veeva ipo kind funni
think still six year later call earli day market better yet
suppos fact investor seem believ chang
percept result hard work veeva part term regular
innov nearli flawless execut alway find graphic
help term lay term veeva product evolut
opportun major firm solut set still correctli
left side adopt curv realli support earli day claim
alway case annual event veeva updat
graphic detail updat disclosur punch line
manag believ firm opportun increas
inclus recent acquir crossix point
unreason think vertic giant get share
given market one key benefit typic ascrib vertic leader
outsiz share gain larg part due referenc gener high
margin advantag wast sale cycl veeva tam continu
grow put perspect goal revenu worri
market opportun gate factor firm growth
enterpris softwar softwar servic
get simpl term roughli
doubl commerci cloud quadrupl develop cloud
next six year impli low double-digit growth commerci
cloud roughli compound-annual-growth-rate develop suit key
continu commerci growth geograph expans within larg
enterpris account traction add-on like align event newli
introduc approv note leverag embed ai new faster-
growth opportun patient data/analyt brand market team recent
acquir crossix develop side sever effort
get go vault safeti train payment homerun area
investor pay particular attent traction cdm edc
coder workbench growth clinic network intend
connect parti clinic trial sponsor site etc special
edi-lik network secur data exchang
margin front wed make observ vault continu put
upward pressur gross margin grow larger part mix recal
doesnt carri burden royalti payment salesforc like firm
inher profit applic may
bit oper leverag time near term
least would surpris us see firm increas invest
develop sale given firm evolut addit
oper margin today wed note crossix modestli dilut
veeva short-term veeva tradit quit conserv
margin forecast firm say today
think quit unlik margin lower current level
scale noth structur support claim time
everi reason think veeva abl gener oper margin
reach rang
store sale key lever growth key sustain growth vertic
sale model number potenti target compar narrow
abil go deep custom veeva excel front evidenc
increas vault adopt per custom cohort analysi detail
type model depend regular innov
firm view strateg partner mani largest custom veeva
greatli benefit collabor approach product direct
effici come develop product know custom
want buy point number vault per custom steadili
enterpris softwar softwar servic
rise sinc expect trend continu acceler
momentum build develop cloud vault applic
market today there still long way go graphic reflect firm
abil consist post revenu growth far outpac new custom
figur vault adopt continu improv
headwind thought iqvia challeng issu entir tie
product commerci cloud network nitro andi
impact firm core develop cloud effort may
know backstori seri acquisit iqvia assembl
near monopolist hold pharma sale data europ firm
employ anti-competit behavior allow data veeva
solut like data warehous mdm ai tool sale rep
behavior ownership prior vendor began veeva
made three-year effort find amic resolut file anti-trust
enterpris softwar softwar servic
lawsuit iqvia network nitro
expect trial date case sometim meantim
continu expect modest headwind commerci cloud
growth custom leverag iqvia data larg percent
popul wed note manag taken consider
near- long-term target
outsid life scienc ol updat fairli basic veeva
three product qualityon manag document tie qualiti process control
regulatoryon product registr claim librari market claim
reduc legal/regulatori risk sold three highli regul industri
chemic consum packag good cosmet firm
custom includ seven-figur custom largest
approach eight-figur time last year point
veeva see nice progress earli adopt outsid life scienc
effort go forward center maintain enterpris focu
expand refer custom base deliv product
level excel firm built reput life scienc
enterpris softwar softwar servic
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
enterpris softwar softwar servic
period yet restat servic subscript profession servic gross oper incom net comp amort intang tax net share share free total revenu per pct changesubscript servic net expens ratio metricssubscript servic gross pct sale research oper pct changesubscript servic net figur balanc sheet socf
enterpris softwar softwar servic
period yet restat period yet restat sfiscal year-endbal sheetfisc year-endmost million millionsrec activitiesasset net depreci short-term stock-bas account receiv net unbil account chang oper asset liabil defer incom tax account receiv current incom current unbil account defer properti equip capit softwar account defer cost net accru leas right-of-us defer leas intang long-term long-term asset activitiesli sharehold equiti chang market account purchas properti accru payment capit incom tax payment acqusit defer restrict leas current activ defer incom tax proce earli exercis stock leas liabil proce exercis stock long-term sharehold effect exchang liabil sharehold tangibl book
